• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GIP 受体在小鼠棕色脂肪组织中的生理作用。

Physiological roles of the GIP receptor in murine brown adipose tissue.

机构信息

Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada.

Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

Mol Metab. 2019 Oct;28:14-25. doi: 10.1016/j.molmet.2019.08.006. Epub 2019 Aug 10.

DOI:10.1016/j.molmet.2019.08.006
PMID:31451430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6822254/
Abstract

OBJECTIVE

Glucose-dependent insulinotropic polypeptide (GIP) is secreted from the gut in response to nutrient ingestion and promotes meal-dependent insulin secretion and lipid metabolism. Loss or attenuation of GIP receptor (GIPR) action leads to resistance to diet-induced obesity through incompletely understood mechanisms. The GIPR is expressed in white adipose tissue; however, its putative role in brown adipose tissue (BAT) has not been explored.

METHODS

We investigated the role of the GIPR in BAT cells in vitro and in BAT-specific (Gipr) knockout mice with selective elimination of the Gipr within the Myf5 expression domain. We analyzed body weight, adiposity, glucose homeostasis, insulin and lipid tolerance, energy expenditure, food intake, body temperature, and iBAT oxygen consumption ex vivo. High-fat diet (HFD)-fed Gipr mice were studied at room temperature (21 °C), 4 °C, and 30 °C ambient temperatures.

RESULTS

The mouse Gipr gene is expressed in BAT, and GIP directly increased Il6 mRNA and IL-6 secretion in BAT cells. Additionally, levels of thermogenic, lipid and inflammation mRNA transcripts were altered in BAT cells transfected with Gipr siRNA. Body weight gain, energy expenditure, and glucose and insulin tolerance were normal in HFD-fed Gipr mice housed at room temperature. However, Gipr mice exhibited higher body temperatures during an acute cold challenge and a lower respiratory exchange ratio and impaired lipid tolerance at 21 °C. In contrast, body weight was lower and iBAT oxygen consumption was higher in HFD-fed mice housed at 4 °C but not at 30 °C.

CONCLUSIONS

The BAT GIPR is linked to the control of metabolic gene expression, fuel utilization, and oxygen consumption. However, the selective loss of the GIPR within BAT is insufficient to recapitulate the findings of decreased weight gain and resistance to obesity arising in experimental models with systemic disruption of GIP action.

摘要

目的

葡萄糖依赖性胰岛素多肽(GIP)是肠道响应营养摄入而分泌的一种激素,它能促进与进餐相关的胰岛素分泌和脂质代谢。GIP 受体(GIPR)作用的丧失或减弱会导致机体对饮食诱导肥胖产生抗性,但其具体机制尚不完全清楚。GIPR 表达于白色脂肪组织,但它在棕色脂肪组织(BAT)中的潜在作用尚未被探索。

方法

我们在体外和 BAT 特异性(Gipr)敲除小鼠中研究了 GIPR 在 BAT 细胞中的作用,这些小鼠通过在 Myf5 表达域内选择性消除 Gipr 来实现 Gipr 的敲除。我们分析了体重、肥胖程度、葡萄糖稳态、胰岛素和脂质耐受性、能量消耗、摄食量、体温以及离体 BAT 耗氧量。高脂饮食(HFD)喂养的 Gipr 小鼠在室温(21°C)、4°C 和 30°C 环境温度下进行研究。

结果

小鼠 Gipr 基因在 BAT 中表达,GIP 直接增加 BAT 细胞中的 Il6 mRNA 和 IL-6 分泌。此外,用 Gipr siRNA 转染的 BAT 细胞中,产热、脂质和炎症 mRNA 转录物的水平也发生了改变。在室温下饲养的 HFD 喂养 Gipr 小鼠的体重增加、能量消耗以及葡萄糖和胰岛素耐受性均正常。然而,Gipr 小鼠在急性冷应激时表现出更高的体温,在 21°C 时呼吸交换率更低且脂质耐受性受损。相反,在 4°C 下饲养的 HFD 喂养小鼠的体重较低,BAT 耗氧量较高,但在 30°C 下则没有这种情况。

结论

BAT 中的 GIPR 与代谢基因表达、燃料利用和耗氧量的控制有关。然而,在系统破坏 GIP 作用的实验模型中,BAT 中 GIPR 的选择性缺失不足以重现体重增加减少和肥胖抗性的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/ee63712ccad3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/3e61d901b179/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/718a4554daef/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/d2a06df4f5ac/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/cd6fb4e37f5c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/16c68294b1c2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/ee63712ccad3/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/3e61d901b179/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/718a4554daef/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/d2a06df4f5ac/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/cd6fb4e37f5c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/16c68294b1c2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f697/6822254/ee63712ccad3/gr5.jpg

相似文献

1
Physiological roles of the GIP receptor in murine brown adipose tissue.GIP 受体在小鼠棕色脂肪组织中的生理作用。
Mol Metab. 2019 Oct;28:14-25. doi: 10.1016/j.molmet.2019.08.006. Epub 2019 Aug 10.
2
The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice.棕色脂肪组织胰高血糖素受体具有功能,但对于控制小鼠能量平衡并非必需。
Mol Metab. 2019 Apr;22:37-48. doi: 10.1016/j.molmet.2019.01.011. Epub 2019 Feb 5.
3
GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.GIP 受体缺失的小鼠通过改变能量消耗和脂肪组织脂质代谢对高脂肪饮食诱导的肥胖产生抗性。
Am J Physiol Endocrinol Metab. 2021 Apr 1;320(4):E835-E845. doi: 10.1152/ajpendo.00646.2020. Epub 2021 Mar 1.
4
Inhibition of Gastric Inhibitory Polypeptide Receptor Signaling in Adipose Tissue Reduces Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice.抑制脂肪组织中胃抑制多肽受体信号传导可降低高脂饮食喂养小鼠的胰岛素抵抗和肝脂肪变性。
Diabetes. 2017 Apr;66(4):868-879. doi: 10.2337/db16-0758. Epub 2017 Jan 17.
5
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.优化的 GIP 类似物通过 GIPR 激动作用而不是拮抗作用促进小鼠体重降低。
Mol Metab. 2019 Feb;20:51-62. doi: 10.1016/j.molmet.2018.12.001. Epub 2018 Dec 5.
6
Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance.人脂肪组织中 GIP/GIPR 轴的破坏与肥胖和胰岛素抵抗有关。
J Clin Endocrinol Metab. 2014 May;99(5):E908-19. doi: 10.1210/jc.2013-3350. Epub 2014 Feb 10.
7
The transcriptional co-regulator LDB1 is required for brown adipose function.转录共激活因子 LDB1 对于棕色脂肪功能是必需的。
Mol Metab. 2021 Nov;53:101284. doi: 10.1016/j.molmet.2021.101284. Epub 2021 Jun 29.
8
GHS-R in brown fat potentiates differential thermogenic responses under metabolic and thermal stresses.GHS-R 在棕色脂肪中发挥作用,增强代谢和热应激下的不同产热反应。
PLoS One. 2021 Apr 1;16(4):e0249420. doi: 10.1371/journal.pone.0249420. eCollection 2021.
9
Short-term thermoneutral housing alters glucose metabolism and markers of adipose tissue browning in response to a high-fat diet in lean mice.短期的热中性环境会改变瘦小鼠在高脂饮食情况下的葡萄糖代谢以及脂肪组织褐变的标志物。
Am J Physiol Regul Integr Comp Physiol. 2018 Oct 1;315(4):R627-R637. doi: 10.1152/ajpregu.00364.2017. Epub 2018 May 23.
10
The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.葡萄糖依赖性胰岛素释放多肽(GIP)通过中枢神经系统-GIPR 信号来调节体重和食物摄入。
Cell Metab. 2021 Apr 6;33(4):833-844.e5. doi: 10.1016/j.cmet.2021.01.015. Epub 2021 Feb 10.

引用本文的文献

1
Adipose Tissue, at the Core of the Action of Incretin and Glucagon-Based Anti-Obesity Drugs.脂肪组织,肠促胰岛素和基于胰高血糖素的抗肥胖药物作用的核心。
Curr Obes Rep. 2025 Sep 2;14(1):67. doi: 10.1007/s13679-025-00660-w.
2
Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications.基于单体胰高血糖素样肽-1受体激动剂对代谢相关脂肪性肝病及其并发症影响的系统评价。
Diabetol Metab Syndr. 2025 Jul 29;17(1):300. doi: 10.1186/s13098-025-01870-x.
3
A Contemporary Rationale for Agonism of the GIP Receptor in the Treatment of Obesity.

本文引用的文献

1
GIP regulates inflammation and body weight by restraining myeloid-cell-derived S100A8/A9.GIP 通过抑制髓系细胞来源的 S100A8/A9 来调节炎症和体重。
Nat Metab. 2019 Jan;1(1):58-69. doi: 10.1038/s42255-018-0001-z. Epub 2018 Nov 19.
2
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study.联合 GIP 和 GLP-1 输注对超重/肥胖个体的能量摄入、食欲和能量消耗的影响:一项随机、交叉研究。
Diabetologia. 2019 Apr;62(4):665-675. doi: 10.1007/s00125-018-4810-0. Epub 2019 Jan 25.
3
Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
GIP受体激动剂治疗肥胖症的当代理论依据
Diabetes. 2025 Aug 1;74(8):1326-1333. doi: 10.2337/dbi24-0026.
4
The Premise of the Paradox: Examining the Evidence That Motivated GIPR Agonist and Antagonist Drug Development Programs.悖论的前提:审视推动GIPR激动剂和拮抗剂药物研发项目的证据。
J Clin Med. 2025 May 29;14(11):3812. doi: 10.3390/jcm14113812.
5
Glucose-dependent insulinotropic polypeptide (GIP).葡萄糖依赖性促胰岛素多肽(GIP)。
Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28.
6
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice.GIP受体激活白色脂肪组织中无效的钙循环,以增加能量消耗并促使小鼠体重减轻。
Cell Metab. 2025 Jan 7;37(1):187-204.e7. doi: 10.1016/j.cmet.2024.11.003. Epub 2024 Dec 5.
7
The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue.葡萄糖依赖性胰岛素多肽在脂肪组织中的相互作用。
J Endocrinol. 2024 Apr 27;261(3). doi: 10.1530/JOE-23-0361. Print 2024 Jun 1.
8
Advances in the Management of Diabetes and Overweight using Incretin-based Pharmacotherapies.基于肠促胰岛素的药物治疗在糖尿病和超重管理方面的进展。
Curr Diabetes Rev. 2024;20(7):e131123223544. doi: 10.2174/0115733998256797231009062744.
9
Relevance and consequence of chronic inflammation for obesity development.慢性炎症对肥胖发展的相关性及影响
Mol Cell Pediatr. 2023 Nov 14;10(1):16. doi: 10.1186/s40348-023-00170-6.
10
Myoglobin in Brown Adipose Tissue: A Multifaceted Player in Thermogenesis.棕色脂肪组织中的肌红蛋白:产热作用中的多面手。
Cells. 2023 Sep 8;12(18):2240. doi: 10.3390/cells12182240.
优化的 GIP 类似物通过 GIPR 激动作用而不是拮抗作用促进小鼠体重降低。
Mol Metab. 2019 Feb;20:51-62. doi: 10.1016/j.molmet.2018.12.001. Epub 2018 Dec 5.
4
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models.GIPR 拮抗剂单独及与 GLP-1R 激动剂联合在临床前模型中的抗肥胖作用。
Sci Transl Med. 2018 Dec 19;10(472). doi: 10.1126/scitranslmed.aat3392.
5
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.LY3298176,一种新型双重 GIP 和 GLP-1 受体激动剂,用于治疗 2 型糖尿病:从发现到临床概念验证。
Mol Metab. 2018 Dec;18:3-14. doi: 10.1016/j.molmet.2018.09.009. Epub 2018 Oct 3.
6
Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.LY3298176,一种新型双重 GIP 和 GLP-1 受体激动剂,在 2 型糖尿病患者中的疗效和安全性:一项随机、安慰剂对照和阳性对照药物对照的 2 期临床试验。
Lancet. 2018 Nov 17;392(10160):2180-2193. doi: 10.1016/S0140-6736(18)32260-8. Epub 2018 Oct 4.
7
Glucose-dependent insulinotropic polypeptide is required for moderate high-fat diet- but not high-carbohydrate diet-induced weight gain.葡萄糖依赖性胰岛素多肽是适度高脂肪饮食 - 而不是高碳水化合物饮食引起体重增加所必需的。
Am J Physiol Endocrinol Metab. 2018 Jun 1;314(6):E572-E583. doi: 10.1152/ajpendo.00352.2017. Epub 2018 Feb 6.
8
Pro-inflammatory gene expression profile in obese adults with high plasma GIP levels.肥胖成年人中高血浆 GIP 水平与促炎基因表达谱相关。
Int J Obes (Lond). 2018 Apr;42(4):826-834. doi: 10.1038/ijo.2017.305. Epub 2017 Dec 13.
9
Discovery, characterization, and clinical development of the glucagon-like peptides.胰高血糖素样肽的发现、特性鉴定及临床开发。
J Clin Invest. 2017 Dec 1;127(12):4217-4227. doi: 10.1172/JCI97233.
10
The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.双重 GIP/GLP-1 受体激动剂 NNC0090-2746 治疗 2 型糖尿病患者的持续疗效。
Cell Metab. 2017 Aug 1;26(2):343-352.e2. doi: 10.1016/j.cmet.2017.07.011.